Are Antidepressants Addictive? Dependence, Discontinuation, and How Long People Stay On Them

by | Oct 4, 2026 | Blogs, Patient Guides | 0 comments

The prescription has been in your bag for three weeks. You carried it to the pharmacy counter once and walked back out, because someone told you that once you start you never get off it. So you have been managing.

Are antidepressants addictive? It is a question we hear often in our Fort Worth office, and it deserves a straight answer. The answer has two halves. They are not drugs of abuse in the way that phrase usually means. Stopping one can still make you feel unwell.

Both are true at once.

If you are in crisis or thinking about harming yourself right now, call or text 988 to reach the Suicide & Crisis Lifeline, available 24/7, or go to your nearest emergency room. Our line, 817-659-7344, is answered during business hours and is not a crisis line.

Should you stop an antidepressant on your own?

No. If this article makes you want to quit a medication you take, do not stop on your own, and never stop abruptly.

The National Institute of Mental Health is direct. People “should not stop taking a prescribed medication, even if they are feeling better, without the help of a health care provider.” Stopping too soon “may cause unpleasant or harmful side effects.”

You will not find a taper schedule here, and be wary of one anywhere online. It depends on the medication, how long you have taken it, and what else is happening.

Are antidepressants addictive? What the word actually means

Addiction is a specific thing, not a vague sense that a medication has a grip on you.

The National Institute on Drug Abuse defines it as “a chronic disease characterized by drug seeking and use that is compulsive, or difficult to control, despite harmful consequences.” That definition has three moving parts: craving, escalating use, and damage that stacks up.

DSM-5-TR is stricter. As summarized in a National Library of Medicine reference, it grades a substance use disorder against 11 criteria, two of which are tolerance and withdrawal.

One sentence settles most of this argument: “Tolerance and withdrawal in the context of appropriate medical treatment (i.e., pain medication used as prescribed) do not count as criteria for an SUD.”

Your body adapting to a medication you take as prescribed is not, by itself, evidence of addiction. It is expected biology.

Three words that get mixed up

The word What it describes
Addiction (substance use disorder) Compulsive use despite harm, with craving and loss of control
Physical dependence The body has adapted, so removing the medication produces symptoms
Discontinuation syndrome The symptoms of that adaptation, in the days after a dose is lowered or stopped

 

Prescribing information for sertraline, one commonly prescribed SSRI (selective serotonin reuptake inhibitor), states that it “is not a controlled substance.” In a study designed to test whether a drug is likely to be misused, it “did not produce the positive subjective effects indicative of abuse potential, such as euphoria or drug liking.”

Nobody takes an extra sertraline for the feeling.

One honest caveat. Bupropion’s labeling reports mild amphetamine-like effects from a high single dose, and notes that higher doses “might be modestly attractive to those who abuse CNS stimulant drugs.”

Cleveland Clinic puts it plainly: “No, antidepressant medicines aren’t addictive.” The label language above describes sertraline, and antidepressants are not one interchangeable class. Ask your prescriber about yours.

Antidepressant withdrawal symptoms are real

Sertraline’s FDA prescribing information lists adverse reactions after stopping serotonergic antidepressants, the group that includes SSRIs and SNRIs, “particularly after abrupt discontinuation,” including nausea, sweating, dysphoric mood (a low, unpleasant mood state), irritability, dizziness, sensory disturbances such as electric shock sensations, anxiety, headache, insomnia, and seizures.

That is a list of what has been reported, not what to expect. Cleveland Clinic says these symptoms vary in severity but are usually mild. The serious end is rare, and it is one more reason not to stop abruptly.

How common is it? A 2024 review and meta-analysis in The Lancet Psychiatry pooled 79 studies and 21,002 patients. At least one discontinuation symptom appeared in 31 percent of people who stopped an antidepressant, against 17 percent who stopped placebo. Allowing for that background rate, the authors put the incidence attributable to stopping at about 15 percent, one in six to seven.

An average hides the tails. Some barely notice; some have a hard time. If that is you, you are not imagining it.

Which antidepressant matters too. The same review found symptoms reported more often with some than others: desvenlafaxine, venlafaxine, imipramine, and escitalopram. Severe symptoms were much less common: about 2.8 percent after an antidepressant, against 0.6 percent after placebo. That is part of what your prescriber weighs, not a reason to switch on your own.

A 2021 Cochrane review of 33 randomized trials and 4,995 participants rated every included trial at high risk of bias and could “not make any firm conclusions about effects and safety of the approaches studied to date.” Its reviewers named the trap: “bias due to confounding withdrawal symptoms with symptoms of relapse of depression.” People who stopped did relapse more often than those who continued, roughly two to three times as often, at very low certainty.

In the room, timing and character usually separate them. Discontinuation symptoms tend to arrive within days of a change and feel physical: dizziness, electric-shock sensations, flu-like aching, nausea. Returning depression builds over weeks and looks like the illness did before. That is what we listen for at a follow-up.

How long do you stay on antidepressants?

There is no default answer, and the first visit is not where it gets decided.

Antidepressants usually take four to eight weeks to work, NIMH notes, and sleep, appetite, and concentration often improve before mood does. If nothing has moved after a fair trial, that is information, and it opens a conversation about treatment-resistant depression options.

After you feel better, guidance points toward continuing rather than stopping the day the fog lifts. Cleveland Clinic’s framing is at least six months after you start feeling better, longer if depression is long-term, recurrent, or very severe. An American Academy of Family Physicians summary of the VA/DoD major depressive disorder guideline reports a similar minimum after remission.

Past that it is individual, revisited with a prescriber over time. Stopping does not mean depression has been cured, only that you and your clinician judged this a reasonable time to try.

Can antidepressants trigger mania in bipolar disorder?

It can happen, which is why a careful diagnostic history matters before an antidepressant is started.

Sertraline’s labeling states that “in patients with bipolar disorder, treating a depressive episode with sertraline or another antidepressant may precipitate a mixed/manic episode.” It tells prescribers to screen for personal or family history of bipolar disorder, mania, or hypomania, a milder form of mania. The same section notes that patients with bipolar disorder were generally excluded from those controlled trials, so the label cannot say how often a switch happens in people who have it. That is a question for a diagnostic history, not a package insert.

A 2013 International Society for Bipolar Disorders task force report, in the American Journal of Psychiatry, found a “striking incongruity between the wide use of and the weak evidence base for” antidepressants in bipolar disorder. Its conclusion for bipolar I: an antidepressant should accompany a mood stabilizer, not stand alone. That report dates to 2013 and the question is still debated, which is why bipolar disorder deserves a real evaluation.

Should you tell your prescriber you did not fill it?

Yes. There is one warning worth knowing first, though probably not the one you fear.

Antidepressant labeling carries an FDA boxed warning: in short-term studies, antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. In the pooled analyses reported in sertraline’s labeling, that increase appeared under 18 and at ages 18 to 24, while figures for 25 to 64 and for 65 and older showed a decrease. NIMH puts it plainly: in some cases, people under 25 may experience an increase in suicidal thoughts or behavior, “especially in the first few weeks after starting the medication or when the dose is changed.”

We treat adults 18 and older, so that younger band is in scope here. NIMH adds that anyone starting an antidepressant should be watched closely during those first weeks. That is why early treatment comes with follow-up appointments, not a refill and a wave. If your mood, agitation, or thoughts of self-harm worsen, call your prescriber rather than wait. If you are having thoughts of harming yourself, call or text 988.

If fear of dependence is why that prescription is still in your bag, that is not a private failing to hide. Saying “I did not fill it, and here is why” lets a prescriber address the real worry. “I am not sure I want to be on this” is a legitimate sentence to say out loud, and there is more in what happens when you are truly honest with your psychiatrist.

Frequently asked questions

Are antidepressants addictive?
Not in the usual sense. The National Institute on Drug Abuse defines addiction as compulsive drug seeking and use despite harmful consequences. Sertraline’s prescribing information states it is not a controlled substance and produced no euphoria or drug liking in an abuse-liability study.

What is the difference between dependence and addiction?
Dependence means the body has adapted, so stopping or lowering the dose can produce symptoms. Addiction adds craving, loss of control, and use despite harm. A National Library of Medicine reference on DSM-5-TR criteria states that tolerance and withdrawal during appropriate medical treatment do not count.

What is antidepressant discontinuation syndrome?
It is the cluster of symptoms that can follow stopping an antidepressant, especially abruptly. Cleveland Clinic describes symptoms typically starting within two to four days and typically lasting less than two months, including flu-like feelings, insomnia, nausea, dizziness, tingling, anxiety, and irritability.

Is it hard to come off antidepressants?
For some people, yes. A 2024 meta-analysis in The Lancet Psychiatry found at least one discontinuation symptom in 31 percent of people stopping an antidepressant versus 17 percent stopping placebo, and severe symptoms in about 2.8 versus 0.6 percent. Talk it through with your prescriber.

The bottom line

Dependence and addiction are not the same thing, and the difference is not a technicality. The criteria for a substance use disorder exclude tolerance and withdrawal that occur during appropriate medical treatment. Discontinuation symptoms are still real, they range from barely noticeable to genuinely difficult, and the research on how best to stop is thin. If fear of never getting off it is why your prescription is still unfilled, that is one of the most useful things you can bring to an appointment.

Talk with us

If you are in Fort Worth or the surrounding North Texas area and what you have read here sounds familiar, we would be glad to talk it through with you. The Institute for Advanced Psychiatry is an outpatient practice at 6800 Harris Parkway, Suite 100, treating adults 18 and older. You can request an appointment or call 817-659-7344.

If you are in crisis or thinking about harming yourself, please do not wait for an appointment. Call or text 988 to reach the Suicide & Crisis Lifeline, available 24/7, or go to your nearest emergency room.

Sources

  1. National Institute on Drug Abuse. “Understanding Drug Use and Addiction DrugFacts.” 2018. https://nida.nih.gov/publications/drugfacts/understanding-drug-use-addiction
  2. National Library of Medicine, NCBI Bookshelf. “Substance Use Screening, Risk Assessment, and Use Disorder Diagnosis in Adults – Table 3, DSM-5-TR Criteria for Diagnosing and Classifying Substance Use Disorders.” 2021. https://www.ncbi.nlm.nih.gov/books/NBK565474/table/table-3/
  3. National Institute of Mental Health. “Mental Health Medications.” Accessed 2026. https://www.nimh.nih.gov/health/topics/mental-health-medications
  4. National Institute of Mental Health. “Depression.” Accessed 2026. https://www.nimh.nih.gov/health/publications/depression
  5. DailyMed, U.S. National Library of Medicine. “Sertraline Tablet, Film Coated – Full Prescribing Information (Boxed Warning; Sections 5.1, 5.4, 5.5, 9.1, 9.2).” Revised 9/2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dac437f-b5ef-42dd-aa0b-1f4b9b45ef43
  6. DailyMed, U.S. National Library of Medicine. “Bupropion Hydrochloride Tablet, Film Coated, Extended Release – Full Prescribing Information (Section 9.2, Abuse).” Accessed 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc344f7c-0eb3-4e63-a09e-b682acca2bb5
  7. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. “Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.” The Lancet Psychiatry. 2024;11(7):526-535. https://pubmed.ncbi.nlm.nih.gov/38851198/
  8. Van Leeuwen E, van Driel ML, Horowitz MA, Kendrick T, Donald M, De Sutter AI, Robertson L, Christiaens T. “Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.” Cochrane Database of Systematic Reviews. 2021;4:CD013495. https://pubmed.ncbi.nlm.nih.gov/33886130/
  9. Pacchiarotti I, et al. “The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.” American Journal of Psychiatry. 2013;170(11):1249-1262. https://pubmed.ncbi.nlm.nih.gov/24030475/
  10. Cleveland Clinic. “Antidepressant Discontinuation Syndrome.” Accessed 2026. https://my.clevelandclinic.org/health/diseases/25218-antidepressant-discontinuation-syndrome
  11. Cleveland Clinic. “Antidepressants.” Accessed 2026. https://my.clevelandclinic.org/health/treatments/9301-antidepressants-depression-medication
  12. American Academy of Family Physicians. “Management of Major Depression: Guidelines From the VA/DoD.” American Family Physician. 2023. https://www.aafp.org/pubs/afp/issues/2023/0300/practice-guidelines-depression.html

Medical disclaimer

This article is for general education and is not medical advice, a diagnosis, or a treatment recommendation for any individual. Reading it does not create a physician-patient relationship. Treatment decisions, including whether any medication or procedure is appropriate for you, should be made with a qualified clinician who knows your history. Do not start, stop, or change a psychiatric medication without talking to your prescriber. If you are experiencing a medical or mental health emergency, call 911 or 988.

Request an Appointment

Note: This form is for general inquiries only. For urgent mental health needs, please call us directly at 817-659-7344 or call 988 (Suicide & Crisis Lifeline).

By submitting, you agree to our Privacy Policy. We typically respond within 1 business day.